Mankind Pharma has approved two major strategic decisions to sharpen its long-term growth strategy. The company will sell its hospitality business for Rs49 crore.
Reproductive rights have come sharply into focus in India as the National Commission for Women (NCW) initiates a comprehensive review of the regulatory framework
The expanding field of peptide-based inquiry continues to uncover fragments whose functional identities extend far beyond their origins. Among these, BPC-157, derived from a segment
Wegovy is making a strong comeback in India's fast-growing weight loss drug market as generic weight loss drugs begin to lose momentum.
The weight loss pills race is entering a new phase as smaller biotech companies move closer to challenging Big Pharma in the fast-growing obesity drug market.
Sun Pharma's latest acquisition of Organon is worth 12 billion, which raises the Mergers and Acquisitions activity in India for the next four years
Glenmark has expanded its presence in the US pharmaceutical market with the launch of its Fast-Acting Schizophrenia Injection, a generic version of Olanzapine for Injection, 10 mg/vial.
The Hyderabad Pharma Firm, Shantha Biologics, has secured a major manufacturing agreement with Novo Nordisk, marking another milestone for India's pharmaceutical sector.
EMA has recently approved Lupin's drug capsules that could change the care for the rare muscle disorder, non-dystrophic myotonias that is seen in one among a million people
New hormone plant has become the latest milestone for Corona Remedies as the company strengthens its position in women's healthcare with the commercial launch of a dedicated hormone manufacturing facility in Bhayla, Ahmedabad.
, CDSCO.jpg)